دورية أكاديمية
Complete Tumor Regression by Liposomal Bortezomib in a Humanized Mouse Model of Multiple Myeloma.
| العنوان: | Complete Tumor Regression by Liposomal Bortezomib in a Humanized Mouse Model of Multiple Myeloma. |
|---|---|
| المؤلفون: | Deshantri AK; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.; Biological Research Pharmacology Department, Sun Pharma Advanced Research Company Ltd. Vadodara, India., Fens MHAM; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Ruiter RWJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Metselaar JM; Enceladus Pharmaceuticals, Naarden, the Netherlands.; Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany., Storm G; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Department of Biomaterials Science and Technology, University of Twente, Enschede, The Netherlands., Mandhane SN; Biological Research Pharmacology Department, Sun Pharma Advanced Research Company Ltd. Vadodara, India., Graat GHM; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Metabolic and Endocrine Diseases, University Medical Center Utrecht, Utrecht, The Netherlands., Lentjes EGW; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Metabolic and Endocrine Diseases, University Medical Center Utrecht, Utrecht, The Netherlands., Yuan H; Kuros Biosciences BV, Bilthoven, The Netherlands., de Bruijn JD; Kuros Biosciences BV, Bilthoven, The Netherlands.; The School of Engineering and Materials Science, Queen Mary University of London, London, United Kingdom., Mutis T; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Martens ACM; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Groen RWJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Schiffelers RM; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. |
| المصدر: | HemaSphere [Hemasphere] 2020 Aug 27; Vol. 4 (5), pp. e463. Date of Electronic Publication: 2020 Aug 27 (Print Publication: 2020). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Publication: 2024- : [Hoboken, NJ] : Wiley Original Publication: [Philadelphia, PA] : Wolters Kluwer Health, Inc., [2017]- |
| References: | J Control Release. 2019 Feb 28;296:232-240. (PMID: 30682443) Int J Pharm X. 2019 Mar 23;1:100011. (PMID: 31517276) Curr Cancer Drug Targets. 2011 Mar;11(3):239-53. (PMID: 21247388) Neoplasia. 2005 Feb;7(2):118-27. (PMID: 15802017) J Liposome Res. 2006;16(3):185-94. (PMID: 16952873) J Liposome Res. 2008;18(1):47-57. (PMID: 18348071) Clin Pharmacokinet. 2012 Dec;51(12):823-9. (PMID: 23018466) Clin Cancer Res. 2015 Jun 15;21(12):2802-10. (PMID: 25398450) Oncotarget. 2016 Jun 14;7(24):36382-36394. (PMID: 27144331) Nat Rev Clin Oncol. 2017 Jul;14(7):417-433. (PMID: 28117417) Blood. 2012 Jul 19;120(3):e9-e16. (PMID: 22653974) Cancer Metastasis Rev. 2017 Dec;36(4):561-584. (PMID: 29196868) Cancer Microenviron. 2011 Dec;4(3):325-37. (PMID: 21735169) J Control Release. 2018 Oct 10;287:194-215. (PMID: 30165140) J Control Release. 2016 Dec 10;243:243-249. (PMID: 27773734) Cancer Metab. 2017 Aug 29;5:7. (PMID: 28855983) Drug Des Devel Ther. 2019 May 16;13:1707-1716. (PMID: 31190749) |
| تواريخ الأحداث: | Date Created: 20200914 Latest Revision: 20210225 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC7455224 |
| DOI: | 10.1097/HS9.0000000000000463 |
| PMID: | 32923984 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2572-9241 |
|---|---|
| DOI: | 10.1097/HS9.0000000000000463 |